Provincial anti-cancer drug price reduction officially started?

Provincial anti-cancer generic medical insurance payment standard will be adjusted this time! Today, Sichuan Medical Insurance Administration officially released the announcement on inviting relevant pharmaceutical manufacturers to participate in the negotiation on payment price of bortezomib and lenalidomide generic medical insurance According to the relevant requirements, the negotiation work was carried out for two generic drugs, bortezomib and lenalidomide, which had been published on the website of the provincial health planning bidding and procurement platform The target of negotiation is the manufacturers of bortezomib and lenalidomide, which have been published on the website of Sichuan provincial health planning bidding and procurement platform The focus of the negotiation is to negotiate the payment price of generic medicine, the decrease rate of medicine and the corresponding policies of medical insurance In November 2015, the national health and Family Planning Commission officially launched the national drug price negotiation pilot, and five drugs involving three diseases were included in the negotiation scope In February 2017, the new national medical insurance catalog was released Subsequently, after negotiations with relevant enterprises, 36 of them were successful On July 13 of that year, the Ministry of human resources and social security of the people's Republic of China officially issued the notice on the inclusion of 36 kinds of drugs in the category B scope of the national basic medical insurance, work injury insurance and maternity insurance drugs catalogue, with bortezomib and lenalidomide listed prominently (as shown in the figure, two varieties are listed in the list of 36 countries) On October 27, 2017, Sichuan Provincial Health and Family Planning Commission made relevant requirements on "directory of national basic medical insurance, industrial injury insurance and maternity insurance drugs (2017 Edition)" and notice on 36 national negotiation drug centralized purchase "and included all specifications of packaging products under 36 national negotiation drugs such as lalutide injection into online centralized purchase" national negotiation drug " In the category of "products", direct online purchase is implemented Among them, all products that have been included in the scope of Sichuan Province's centralized online purchase are directly transferred into the category of "national negotiated drugs", and the online purchase price is adjusted according to the payment standard of medical insurance negotiated by the state; all products that are not included in the scope of Sichuan Province's centralized online purchase are added and supplemented in time, and medical institutions can, according to clinical needs, pay for medical insurance negotiated by the state Pay for the standard purchase of related drugs, and supplement the relevant purchase data after the official supplement to the Internet At present, the provinces have successively carried out the price reduction of anti-cancer drugs Taking Liaoning Province as an example, not long ago, the office of the leading group for centralized procurement of drugs and medical consumables of medical institutions in Liaoning Province officially issued the announcement on centralized procurement of drugs for medical institutions in 2018 (No 1), which includes generic drugs negotiated by the state Among the 13 specifications of Liaoning version, the generic drugs of the above two products are included (below) However, from the perspective of the organizer, Liaoning is led by the leading group office for centralized procurement of drugs and medical consumables of medical institutions in Liaoning Province, which is set up by many departments In Sichuan Province, the medical insurance administration of Sichuan province organizes the negotiation of "drug reduction" Some people don't understand why the price of anti-cancer generic drugs and the payment price of medical insurance should be adjusted first at the gate of consistency evaluation It has been pointed out that the generic drugs only copy the main molecular structure of the original research drugs, saving time, capital and labor, and the cost of research and development is low, and the price of the original research drugs is often accompanied by a substantial drop in the market! The author understands that at this time, the price of anti-cancer generic drugs should be adjusted for two reasons One is to adjust the price of anti-cancer generic drugs in advance, which can first meet the needs of the majority of patients in China Second, after the price adjustment, the price of anti-cancer generic drugs will be an important price reference standard Once the relevant products pass the consistency evaluation, then the original research drug will face the competition from two perspectives: when centralized procurement, it will compete with the drugs passing the consistency evaluation in the same group According to the relevant policies of the special procurement draft for anticancer drugs that have not been circulated for a long time, perhaps in the next step of classified procurement of anticancer drugs, for the drugs purchased by bidding, we will continue to carry out two envelope review procurement, for the generic drugs that have passed the consistency evaluation, in principle, they will be included in the same bidding group as the original drugs, and bidding procurement will be conducted according to the same rules That is to say, the actual purchase price and medical insurance payment price of the drugs through the consistency evaluation will become a very clear benchmark If the original research can accept the relevant price given according to this standard, then it can be used in clinical synchronously, if not, then it will be out of the game The second point is that even in the future, it can also be purchased in clinical practice, according to the provisions of "opinions on reforming and improving the supply guarantee and use policy of generic drugs" issued by the State Council, that is, "promoting the alternative use of generic drugs The generic drugs that are consistent with the quality and efficacy of the original research drugs shall be included in the list of interchangeable drugs with the original research drugs " It will be a matter of two opinions whether to use the original research or not Unless the purchase price and the payment price of medical insurance are roughly the same or not much different Specifically in the field of first-line procurement, for a large number of drugs and original research drugs that have passed the consistency evaluation, first-line doctors must select the most appropriate drugs with the most cost-effective when they are used in clinical practice The role of pharmaceutical management and pharmacotherapeutics Committee in medical institutions is bound to be further fully played to enhance the procurement strength of drugs that have passed the consistency evaluation Up to now, four batches of generic drug conformity evaluation lists have been released, with a total of 41 product specifications, 12 of which belong to the 289 catalogue of base drugs In addition, on May 21 this year, when the State Drug Administration issued the fourth batch of list, it pointed out that generic drugs included in the list of interchangeable drugs with the original research drugs, i.e the list of drugs on the market in China, could use the mark of "pass consistency evaluation" With the approaching of the end of 2018, the data of drug clinical trial registration platform is increasing day by day According to the statistics of e-linked bidding and procurement, as of May 19, 2018, there are 5755 registration numbers, 308 involving 289 directories, of which 228 are in progress, accounting for 74.0%; 76 have been completed, accounting for 24.7%; 4 have been suspended actively, accounting for 1.3% It can be seen that, in the context of rapid work related to consistency evaluation, all regions began to reduce the price of anti-cancer generic drugs in advance, and the final target is actually the original drug Finally, the effect of one stone and four birds is achieved This is a game that is conducive to encouraging the upgrading of the domestic pharmaceutical industry, is conducive to the effective control of medical insurance funds, and is also conducive to the effective protection of the rights and interests of consumers This is exactly: people all Zha material clean dust lapel, I also in the chess Cunyin I don't know who I am I'm easy to talk with the world You mistakenly made the mechanism saying that at the beginning of Lao Tzu's life, he didn't win The overall situation should be clear and bright